Abnormal serum IGF-II transport in non-islet cell tumor hypoglycemia results from abnormalities of both IGF binding protein-3 and acid labile subunit and leads to elevation of serum free IGF-II

[1]  Y. Hasegawa,et al.  Measurement of free insulin-like growth factor-I using immunoradiometric assay. , 1994, Journal of immunoassay.

[2]  J. Frystyk,et al.  Free insulin‐like growth factors (IGF‐I and IGF‐II) in human serum , 1994, FEBS letters.

[3]  R. Baxter,et al.  Serum "big insulin-like growth factor II" from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  K. Takano,et al.  Characterization of insulin-like growth factor II (IGF-II) and IGF binding proteins in patients with non-islet-cell tumor hypoglycemia. , 1993, Endocrine journal.

[5]  E. Froesch,et al.  Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? , 1992, The Journal of clinical investigation.

[6]  W. Daughaday,et al.  Measurement of derivatives of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia. , 1992, The Journal of clinical endocrinology and metabolism.

[7]  J. Holly,et al.  The insulin-like growth factors and their binding proteins in a case of non-islet-cell tumour-associated hypoglycaemia. , 1991, The Journal of endocrinology.

[8]  R. Baxter,et al.  Impaired formation of the ternary insulin-like growth factor-binding protein complex in patients with hypoglycemia due to nonislet cell tumors. , 1991, The Journal of clinical endocrinology and metabolism.

[9]  W. Lee,et al.  Measurement of insulin-like growth factor-II in physiological fluids and tissues. I. An improved extraction procedure and radioimmunoassay for human and rat fluids. , 1991, Endocrinology.

[10]  M. Binoux,et al.  Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia. , 1990, The Journal of clinical investigation.

[11]  D. Powell,et al.  Characterization of insulin-like growth factor-binding proteins in human serum from patients with chronic renal failure. , 1990, The Journal of clinical endocrinology and metabolism.

[12]  D. Powell,et al.  IGF Binding Proteins in Growth-Retarded Children with Chronic Renal Failure , 1989, Pediatric Research.

[13]  R. Baxter,et al.  Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[14]  W. Daughaday,et al.  Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[15]  E. Froesch,et al.  Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. , 1987, The New England journal of medicine.

[16]  R. Baxter,et al.  Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma. , 1986, The Journal of clinical investigation.

[17]  H. Harter,et al.  Uremia reduces serum insulin-like growth factor I, increases insulin-like growth factor II, and modifies their serum protein binding. , 1982, The Journal of clinical endocrinology and metabolism.

[18]  E. Froesch,et al.  Is extrapancreatic tumor hypoglycemia associated with elevated levels of insulin-like growth factor II? , 1982, The Journal of clinical endocrinology and metabolism.

[19]  W. Daughaday,et al.  Characterization of somatomedin binding in human serum by ultracentrifugation and gel filtration. , 1982, The Journal of clinical endocrinology and metabolism.

[20]  R. Baxter,et al.  Insulin-like growth factor-binding protein-3 is functionally normal in pregnancy serum. , 1992, The Journal of clinical endocrinology and metabolism.